In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS)Carlotta Ranieri, Nicoletta Resta|Neurogenetics|2018Cited by 83
Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 InhibitorsDaria Carmela Loconte, Nicoletta Resta|PLoS ONE|2015Cited by 81